Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 2009 Apr 20;77(7):2650–2656. doi: 10.1128/IAI.00256-09

The Arginine Catabolic Mobile Element Is Not Associated with Enhanced Virulence in Experimental Invasive Disease Caused by the Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genetic Background ▿

Christopher P Montgomery 1,*, Susan Boyle-Vavra 2, Robert S Daum 2
PMCID: PMC2708564  PMID: 19380473

Abstract

USA300 has become the predominant community-associated methicillin (meticillin)-resistant Staphylococcus aureus (CA-MRSA) genetic background in most U.S. communities. The reasons for the dominance of this genetic background are unclear, but the presence of the recently identified arginine catabolic mobile element (ACME) in the USA300 genome has been advocated as one possibility. CA-MRSA clinical isolates (USA300) differing in the presence or absence of ACME and a USA300 wild-type/ACME deletion mutant pair were analyzed for in vitro expression of global regulatory genes and production of virulence factors. The virulence of these isolates was compared in rodent models of necrotizing pneumonia and skin infection. There was no significant difference in the expression of selected genes mediating virulence (hla, lukSF-PV, agr, saeRS) among the isolates tested, regardless of the presence of ACME. There was a higher abundance of α-hemolysin in culture supernatants among ACME-positive isolates than among ACME-negative isolates, but there was no significant difference in the levels of protein A. The presence of ACME was not associated with increased virulence in a rat model of necrotizing pneumonia, as assessed by mortality, in vivo bacterial survival, and severity of lung pathology. Nor was the presence of ACME associated with increased dermonecrosis in a model of skin infection. We conclude that ACME is not necessary for virulence in rodent models of CA-MRSA USA300 pneumonia or skin infection.


The community-associated methicillin (meticillin)-resistant Staphylococcus aureus (CA-MRSA) USA300 genetic background has become the dominant background causing epidemic disease in most of the United States (9, 13, 18). The reason for the dominance of clone USA300 is unclear, but it likely results, at least in part, from upregulation of multiple regulatory genes, including agr (RNAIII), sarA, and saeRS (16). These regulatory elements coordinately control the expression of numerous toxins and virulence factors in a growth-phase-dependent fashion, including the pore-forming toxins α-hemolysin (encoded by hla) and Panton-Valentine leukocidin (PVL; encoded by lukSF-PV), which are upregulated in USA300 isolates in comparison with USA400 (16).

The arginine catabolic mobile element (ACME), present in the genome of USA300 isolates which contain the staphylococcal cassette chromosome mec type IVa element (10), has been postulated to play a role in the emerging dominance of the USA300 background (7). ACME, previously identified in the commensal species Staphylococcus epidermidis, contains loci which encode at least 33 genes (7). One of these loci, arcABCD, encodes several genes important in arginine catabolism that facilitate survival in acidic environments in Streptococcus pyogenes (6). These genes are in addition to the arc operon present in all S. aureus genomes sequenced to date; thus, the arc operon in the ACME element is an additional, although nonidentical, arginine catabolic operon. This observation has led to speculation that ACME confers on USA300 an enhanced virulence or ability to colonize the skin (7). Also present in ACME is an operon, opp-3, which comprises five genes that, together, encode a putative oligopeptide permease (Opp). Deletion of a homologous opp in S. pyogenes impaired virulence and alters the regulation of virulence factor expression (20). ACME also contains other genes, the majority of which have yet to be characterized (7).

Diep et al. recently studied the effect of ACME on interstrain competitive fitness in a rabbit bacteremia model by using an ACME deletion mutant in the USA300 background (8). In coinfection studies consisting of simultaneous inoculation of rabbits with a wild-type USA300 parent strain and an isogenic ACME deletion mutant, they recovered the parent strain in greater numbers than the deletion mutant from the lungs, spleen, and blood. They concluded that ACME enhances the biologic fitness of USA300.

Despite these results in a single animal model, more information is needed regarding the role of ACME in the possible enhancement of virulence. The purpose of this study was to compare USA300 CA-MRSA clinical isolates differing in the presence or absence of ACME and a USA300 wild-type/ACME deletion mutant isogenic pair in two animal models of S. aureus infection. We hypothesized that, given a proposed role of ACME in facilitating skin infection, USA300 isolates containing ACME would be more virulent in a model of skin infection but that there may be no difference in a model of experimental pneumonia.

MATERIALS AND METHODS

Isolate selection.

A convenience sample of 90 MRSA clinical isolates representing the multilocus sequence type (ST) 8 lineage (presumed to represent USA300) was selected for evaluation from our isolate library at the University of Chicago (5). These isolates caused a variety of disease syndromes associated with CA-MRSA, including skin and soft tissue infections, pneumonia, bacteremia, and sepsis. Each isolate contained the gene encoding the chromosomal arginine deiminase and the lukSF-PV genes encoding PVL. In addition, strains SF8300 (wild-type USA300) and SF8300ax (ACME deletion mutant) were a generous gift from Henry Chambers (University of California San Francisco). They were previously described (8). Strain LAC was generously provided by Michael Otto (National Institutes of Health) (19).

Colony PCR was performed to assess the presence of the ACME-arcA gene (primers 5′-GAGCCAGAAGTACGCGAG-3′ and 5′-CACGTAACTTGCTAGAACGAG-3′) (8). Conditions for PCR were as described previously (8). Eight clinical isolates, three of which contained ACME-arcA and five of which did not, were selected in addition to LAC, SF8300, and SF8300ax for pulsed-field gel electrophoresis (PFGE) (Table 1).

TABLE 1.

CA-MRSA USA300 lukSF-PV-positive isolates used in this study

Isolate Clinical scenario Presence of ACME Reference
SF8300 Necrotizing fasciitis Present 8
LAC Unknown Present 19
923 Abscess Present 16
2145 Pneumonia Present 16
2609 Sinusitis Present This study
SF8300axa Absent 8
451 Skin infection Absent This study
1135 Abscess Absent This study
1185 Abscess Absent This study
1358 Wound infection Absent This study
1866 Pneumonia Absent This study
a

ACME deletion mutant.

PCR was performed with genomic DNA prepared from the selected isolates to assess the presence of the opp-3 locus (primers 5′-GCAAATCTGTAAATGGTCTGTTC-3′ and 5′-GAAGATTGGCAGCACAAAGTG-3′) (8) and to confirm the presence or absence of ACME-arcA. The presence of both of these loci was used to assume the presence of ACME, as previously described (8). The relative virulence of strains LAC, 923, and 2145 in experimental pneumonia in rats was previously characterized (16).

PFGE.

Whole-cell-DNA-containing agarose plugs were prepared and digested with SmaI as described previously (15). Restriction fragments were resolved on a Chef DR-III (PFGE) apparatus (Bio-Rad). Strain LAC served as a standard for the USA300-0114 pulsotype.

In vitro gene expression.

Frozen stock isolates were subcultured on tryptic soy agar (TSA) and incubated overnight at 37°C in tryptic soy broth (TSB) with shaking at 250 rpm. The overnight culture was diluted 1:100 in fresh TSB (flask/volume ratio, 7:1). Bacteria were harvested during the logarithmic growth phase (3 h, optical density at 600 nm [OD600] = 2.4) and frozen at −80°C in RNAprotect (Qiagen). The growth curves of each isolate were similar, as determined by serial OD600 measurements and plating of appropriate serial dilutions at several time points (data not shown). Bacteria were lysed using the Fastprep FastRNA Pro Blue system (Q-BIOgene). Purification of RNA was achieved using the Qiagen RNeasy kit, including treatment with DNase. cDNA was prepared using the high-capacity cDNA Archive kit (Applied Biosystems).

Real-time reverse transcriptase PCR (RT-PCR) was performed to assess the expression of lukF-PV and hla by using an ABI Prism 7300 series RT-PCR thermocycler (Applied Biosystems) as described previously (16). LUX primers (Invitrogen) were designed for saeRS by using a forward primer labeled with 6-carboxyfluorescein (5′-CGTAAAGTCCAAGGGAACTCGTTTTA[FAMc]G-3′) and an unlabeled reverse primer (5′-TTGTTCAACTGGTTGATGATGG-3′). Data were analyzed using the ABI Prism 7300 sequence detection software version 1.2.3 (Applied Biosystems). 16S rRNA expression was used as a control for each isolate. The forward primer (5′-CGGCCTAACTACGTGCCAGCAGC[JOEc]G-3′) was labeled with 6-carboxy-4,5-dichloro-2,7-dimethoxyfluorescein (JOE), and the reverse primer (5′-GCGCTTTACGCCCAATAATTCC-3′) was left unlabeled. Quantification of expression was performed for each isolate relative to strain 451. Northern blot analysis was performed as described previously for agr (RNAIII) (16). RNA (5 μg) was added to each lane, and the equality of loading was confirmed by analysis on a 1.2% agarose-0.66 M formaldehyde gel (data not shown). Densitometry was performed using Molecular Imaging software v4.0 (Kodak). Net intensities were compared between ACME-positive and ACME-negative isolates.

Protein A and α-hemolysin abundance.

S. aureus isolates were grown as described above to stationary growth phase (6 h, OD600 = 6). Cells were pelleted by centrifugation, and supernatants were removed. An equal volume of supernatant was added for each isolate (10 μl). Western blotting was performed on the supernatants to assess protein A abundance using a rabbit monoclonal antibody against protein A (Sigma) and anti-rabbit immunoglobulin G horseradish peroxidase-conjugated secondary antibody (Promega). For α-hemolysin, a mouse polyclonal antibody (Sigma) was used as the primary antibody and anti-mouse immunoglobulin G conjugated to horseradish peroxidase served as the secondary antibody (Promega). The membranes were developed using a chemiluminescent substrate (Pierce). Densitometry was performed as described above.

Preparation of bacteria for inoculation.

To prepare an animal inoculum, a frozen stock of S. aureus was subcultured onto TSA and incubated overnight in TSB at 37°C. The overnight culture was diluted 1:100 in fresh TSB and grown to early stationary phase (OD600 = 3.0). The cells were then centrifuged (3,200 × g for 10 min), washed in phosphate-buffered saline (PBS), and resuspended in PBS. All bacteria in the inocula were quantified by plating serial dilutions on TSA and enumerating the colonies. All animal experiments were conducted in accordance with the regulations of the University of Chicago Institutional Animal Care and Use Committee.

Rat model of CA-MRSA pneumonia.

A model of necrotizing pneumonia in rats has been described (16). Briefly, male Sprague-Dawley rats (Harlan) weighing approximately 300 g each were housed for 7 days prior to inoculation. Animals were anesthetized with ketamine and xylazine. The trachea of each animal was intubated with an 18-gauge angiocatheter (Becton-Dickinson), and S. aureus (9 × 108 CFU) or PBS was instilled (100 μl). The catheter was removed, and the animal was held upright for 15 s. Animals were observed for signs of illness. All surviving animals were euthanized at 24 h with pentobarbital.

Quantitative culture and histopathology in the pneumonia model.

After sacrifice, the left lung was removed and placed in PBS. The lung was washed twice in PBS and homogenized (Tissuemiser; Fisher); serial dilutions of the homogenate were plated on mannitol salt agar for quantification of bacteria. The right lung was placed in formalin, sequentially infiltrated with increasing concentrations of ethanol and xylene, and embedded in paraffin. The tissues were sectioned and stained with hematoxylin and eosin. Lung sections were graded by an observer in a blind manner according to a previously described scoring scheme, with a scale of 0 to 11 (16). The severity of the pulmonary pathology was based on the distribution and extent of inflammation, the presence of necrosis, and the presence of bacterial colonies.

Mouse skin infection model.

Based on the method of Voyich et al. (19), Crl:SKH1-hrBR hairless immunocompetent mice (Charles River) were inoculated by subcutaneous injection in the right flank with 50 μl of S. aureus (1 × 107 CFU) or PBS (bacterial growth described above). The area of dermonecrosis was the product of the length and the width of the lesion.

Statistical analysis.

Mortality rates, the prevalences of necrotizing pneumonia, and the prevalences of dermonecrosis were compared by Fisher's exact test. Quantitative cultures, expression data, and dermonecrosis areas were compared by Student's t test. Pathology scores were compared by the Mann-Whitney U test (SPSS-W v15). Statistical significance was considered present when the P value was <0.05.

RESULTS

Isolate selection.

Of the 90 ST 8 MRSA isolates screened by colony PCR, 8 lacked ACME-arcA. Three ST 8 isolates containing ACME-arcA were selected for further analysis, as were ACME-arcA-positive strains LAC and SF8300. Five ST 8 isolates lacking ACME-arcA and SF8300ax, an isogenic ACME deletion mutant used as a comparator with SF8300, were also chosen (Table 1). All ACME-arcA-positive isolates also contained the opp-3 operon, as determined by PCR, and thus were considered to contain ACME (8). All ACME-arcA-negative isolates also lacked the opp-3 operon and were considered ACME negative.

PFGE.

The pulsotype of all five selected ACME-positive isolates was consistent with USA300-0114 (Fig. 1). The six ACME-negative isolates (including SF8300ax) were also USA300. Each ACME-negative isolate had a single band shift compared with the ACME-positive isolates (Fig. 1). Diep et al. have demonstrated that this shift is due to the absence of ACME (8). Additionally, strains 451, 1185, and 1358 had a single, identical, additional band difference; these strains were also missing a single low-molecular-weight band present in the other strains (Fig. 1).

FIG. 1.

FIG. 1.

PFGE of the CA-MRSA isolates used in this study. Strains SF8300, LAC, 923, 2145, and 2609 were USA300, ACME-positive strains. Strains 451, 1135, 1185, 1358, and 1866 were USA300, ACME-negative strains. All ACME-positive isolates were USA300-0114. Compared with the USA300-0114 isolates, there is a single band difference in all ACME-negative isolates, as described in the text (arrowhead). A second band difference was present in strains 451, 1185, and 1358, unlike with LAC; these strains also lacked a low-molecular-weight band that was present in the other isolates (arrows).

In vitro virulence factor expression and production.

In vitro expression of lukF-PV by RT-PCR varied slightly among the tested isolates, but the magnitude of the variation was small (less than approximately twofold relative to that of strain 451) (Fig. 2B). There was no significant difference between the mean lukF-PV expression in ACME-positive isolates and that among the ACME-negative isolates (P = 0.68). Expression of lukF-PV was unchanged in SF8300ax compared with SF8300. There was also no difference in agr (RNAIII) expression as determined by Northern blotting between ACME-positive isolates and ACME-negative isolates (P = 0.19) (Fig. 2D). Similarly, there was no difference in mean saeRS expression as determined by RT-PCR between ACME-positive isolates and ACME-negative isolates (P = 0.24) (Fig. 2C).

FIG. 2.

FIG. 2.

In vitro gene expression and protein abundance of selected virulence factors. (A) Expression of hla (3 h) as determined by RT-PCR. All results are expressed relative to strain 451. (B) Expression of lukF-PV (3 h) as determined by RT-PCR (also compared with strain 451). (C) Expression of saeRS (3 h) as determined by RT-PCR (also compared with strain 451). Each sample was analyzed in triplicate; error bars represent standard deviations. (D) Abundance of α-hemolysin (Hla) and protein A (Spa) in 6-h culture supernatants determined by Western blotting (10 μl supernatant loaded for each sample) and expression of agr (RNAIII) determined by Northern blotting (3 h) (5 μg RNA loaded for each sample).

The strains we tested had considerable variation in hla expression by RT-PCR; for example, expression was increased >11-fold in strains LAC and 1135 compared with strain 451 (Fig. 2A). Nevertheless, there was no significant difference between the mean hla expression among ACME-positive isolates and the mean among the ACME-negative isolates (P = 0.85). Expression of hla was 1.8-fold higher in SF8300ax than in SF8300.

The abundance of α-hemolysin and protein A (Spa) in 6-h culture supernatants, as assessed by Western blotting, also varied among the isolates (Fig. 2D). ACME-positive isolates had a higher mean abundance of α-hemolysin than did ACME-negative isolates, as assessed by densitometry (P = 0.04). SF8300ax had a 1.4-fold-higher α-hemolysin abundance than SF8300. Although there was some interstrain variability, there was no significant difference between the protein A abundance in culture supernatants of ACME-positive isolates and that in ACME-negative isolates (P = 0.96). In addition, there was a 2.9-fold-higher protein A abundance in SF8300ax than in SF8300.

Comparison of hla expression at 3 h with α-hemolysin protein abundance in 6-h culture supernatants revealed a weak correlation (r = 0.42; data not shown). Expression of hla was more strongly correlated with saeRS expression (r = 0.65, data not shown). This was not surprising, because expression of hla is controlled, at least in part, by the expression of saeRS (21).

Rat model of pneumonia. (i) Clinical isolates.

Two ACME-positive (LAC and 923) and two ACME-negative (1135 and 1866) USA300 isolates were selected for evaluation in the rat model of pneumonia (seven to eight animals/group). Animals inoculated with 9 × 108 CFU of either isolate became ill, characterized by decreased mobility and labored breathing. All animals inoculated with LAC or 1135 died by 24 h; 50% of animals inoculated with 923 and 62% of animals inoculated with 1866 died (Fig. 3A). Interestingly, strains LAC and 1135 had higher expressions of hla and abundances of α-hemolysin than strains 923 and 1866, although the differences were <3-fold (Fig. 2A and D). There was a trend toward higher in vivo bacterial recovery from the lung after inoculation with LAC or 1135 than with 923 and 1866, but these differences were not significant (Fig. 3C). When data from animals inoculated with strains LAC and 923 (ACME positive) and 1135 and 1866 (ACME negative) were pooled, there was no significant difference in survival (P = 0.7) or in vivo bacterial recovery (P = 0.78), regardless of the presence of ACME (Fig. 3B, D). Pulmonary necrosis (pathology score, ≥7) was common after inoculation with LAC (75%), 923 (57%), 1135 (100%), or 1866 (71%). The median pathology scores were nearly the same, regardless of the strain inoculated (Fig. 3E) or the presence of ACME (Fig. 3F).

FIG. 3.

FIG. 3.

Comparison of ACME-positive (strains LAC and 923) and ACME-negative (strains 1135 and 1866) clinical MRSA USA300 isolates (9 × 108 CFU) in a rat model of pneumonia (7 or 8 animals/group). There were strain-specific differences in mortality (A) and in vivo bacterial recovery from the lung (C) that were insignificant when stratified by the presence or absence of ACME. When ACME-positive and ACME-negative isolates were pooled, there was no difference in mortality (B) or in vivo bacterial recovery (D) between groups. There was no significant difference in median pathology scores observed for animals inoculated with any of the four isolates, whether stratified by the inoculated isolate (E) or pooled by the presence or absence of ACME (F). (C and D) Horizontal lines depict the mean bacterial recovery for each group. (E and F) Horizontal lines depict the median score for each group.

(ii) Isogenic wild-type/ACME deletion mutant pair.

There was no significant difference in the clinical features of illness after inoculation with 1 × 109 CFU of either SF8300 or SF8300ax (21 animals/group). Among infected animals, 73% infected with SF8300 and 76% infected with SF8300ax died within 24 h of inoculation (P = 0.77) (Fig. 4A). There was no significant difference in bacterial recovery from the lung, regardless of the presence of ACME (P = 0.42) (Fig. 4B). Necrotizing pneumonia was present in all animals inoculated with either isolate. The median pathology score was slightly higher in animals inoculated with SF8300ax, but the difference was not significant (P = 0.13) (Fig. 4C).

FIG. 4.

FIG. 4.

Comparison of relevant parameters after inoculation with SF8300 (wild-type USA300) or SF8300ax (isogenic ACME deletion mutant) in a rat model of pneumonia (1 × 109 CFU; 21 animals in each group for mortality studies, 7 to 9 animals/group for bacterial recovery and pathology studies). There was no significant difference in survival (A), in vitro bacterial recovery from the lung (B), or median pathology score (C), regardless of the presence or absence of ACME. (B) Horizontal lines depict the mean bacterial recovery for each group. (C) Horizontal lines depict the median score for each group.

Mouse model of skin infection. (i) Clinical isolates.

Mice were inoculated with 1 × 107 CFU of 1 of 10 S. aureus isolates (5 ACME positive, 5 ACME negative; 5 to 20 animals in each group). A local dermonecrotic lesion occurred in 40 of 55 animals (72%) inoculated with an ACME-positive isolate and in 35 of 45 animals (78%) inoculated with an ACME-negative isolate (P = 0.37). The mean maximum areas of dermonecrosis ranged from 19.8 mm2 (strain 2609) to 91.4 mm2 (strain SF8300) in the ACME-positive isolates (Fig. 5A) and from 38.4 mm2 (strain 451) to 90.6 mm2 (strain 1185) in the ACME-negative isolates (Fig. 5B). Although there were strain-specific differences, when data were pooled according to the presence or absence of ACME in the inoculated strain, there was no significant difference in the mean maximum areas of dermonecrosis (ACME positive, 58.6 ± 7.6 mm2; ACME negative, 62.1 ± 11.0 mm2; P = 0.79) (Fig. 5C). The mean maximum area of dermonecrosis was not significantly associated with either expression of hla (r = 0.44) or α-hemolysin abundance (r = 0.2).

FIG. 5.

FIG. 5.

Area of dermonecrosis in mice subcutaneously inoculated with 1 of 10 CA-MRSA USA300 isolates (1 × 107 CFU) differing in the presence or absence of ACME (5 to 20 animals/group). Data are presented as means ± standard errors of the mean. (A) Mean area of dermonecrosis as a function of time after inoculation with one of five ACME-positive clinical isolates. Animals without dermonecrosis were assigned a value of 0. (B) Mean area of dermonecrosis after inoculation with one of five ACME-negative clinical isolates (5 to 15 animals/group). (C) Pooled data for animals inoculated with ACME-positive or ACME-negative isolates.

(ii) Isogenic wild-type/ACME deletion mutant pair.

To further define the role of ACME in experimental skin infection, mice were inoculated with 1 × 107 CFU of SF8300 or SF8300ax (24 or 25 animals/group). Dermonecrosis was present in 22/25 (88%) animals inoculated with SF8300 and 21/24 (88%) animals inoculated with SF8300ax (P = 0.65). The mean maximal area of dermonecrosis was slightly greater after inoculation with SF8300 (80.4 ± 10.2 mm2) than with SF8300ax (71.2 ± 10.8 mm2), but the difference was not significant (P = 0.53) (Fig. 6A). There was no difference in the appearances of lesions after inoculation with SF8300 or SF8300ax (Fig. 6B).

FIG. 6.

FIG. 6.

Dermonecrosis after infection with SF8300 (wild-type USA300) or SF8300ax (isogenic ACME deletion mutant). (A) Mean area of dermonecrosis versus time after infection with SF8300 or SF8300ax (24 to 25 animals/group). Data are shown as means ± standard errors of the mean. (B) Representative lesions observed after inoculation with SF8300 (ACME+) or SF8300ax (ACME−).

DISCUSSION

Our study demonstrated no difference between the virulence of clinical MRSA USA300 isolates which contain ACME-arcA and opp-3, and therefore presumably ACME, and that of MRSA USA300 isolates which lack the element, in a rat model of necrotizing pneumonia and a mouse model of skin infection. These findings were strengthened by the observation that there was also no significant difference in virulence in either model after inoculation with SF8300 (wild-type USA300) or SF8300ax (isogenic ACME deletion mutant).

The role of ACME in CA-MRSA infection remains to be defined. Diep et al. introduced the designation type I ACME to describe an element that contains the full complement of genes described in the sequenced USA300 genomes (7, 8, 12). Smaller genetic elements containing the ACME-arc locus, but not opp-3, were occasionally found in USA100 and USA1000 MRSA isolates (8). Although it is possible that the clinical isolates we studied did not contain type I ACME, this is unlikely because Diep et al. showed that all USA300 strains they studied that contained ACME-arcA and opp-3 also contained type I ACME (8). Furthermore, we found no significant difference in virulence after infection with SF8300 or SF8300ax, in which the entire type I ACME was deleted.

It is noteworthy that our ACME-positive and ACME-negative USA300 MRSA isolates were equally virulent in the skin infection model we employed. A difference was hypothesized since a role for ACME in skin colonization had been postulated (7). However, we did not study colonization, but rather virulence, i.e., the ability of an isolate to cause disease after inoculation.

Our data extend the studies of Diep et al. (8). They coinoculated rabbits intravenously with equal inocula of SF8300 and SF8300ax. They recovered the wild-type isolate in greater numbers than the ACME deletion mutant and concluded that the deletion of ACME resulted in impaired competitive fitness of CA-MRSA USA300 (8). Considering the results of both studies, it appears that competitive fitness does not translate into greater potential to cause disease in a noncompetitive environment. It is also possible that the molecular determinants of MRSA virulence differ for rabbits and rodents. Additional study will be needed to clarify these concepts.

Interestingly, we found that the abundance of α-hemolysin was higher among the ACME-positive isolates than among the ACME-negative isolates we tested. Strains LAC (ACME positive) and 1135 (ACME negative), which were slightly more virulent in the necrotizing pneumonia model than were strains 923 (ACME positive) and 1866 (ACME negative), had higher expression of hla and α-hemolysin abundance. This is not surprising, as this toxin has been demonstrated to play a key role in the pathogenesis of necrotizing pneumonia (2, 4). There was no significant correlation, however, of either hla expression or α-hemolysin abundance to virulence in the dermonecrosis model. The significance of this is unknown, as the role of hla in CA-MRSA skin disease has not been reported.

Protein A and PVL are thought to be important in the pathogenesis of invasive CA-MRSA disease, although the role of PVL has been controversial (1, 3, 11, 14, 17, 19). Expression of both of these virulence factors, in addition to hla, is controlled in part by the global regulators agr and saeRS. We found no significant difference in the amounts of protein A in 6-h culture supernatants, expression of lukF-PV, expression of agr (RNAIII), or expression of saeRS, regardless of the presence or absence of ACME in clinical isolates. There was also no significant difference between the isogenic pair SF8300 and SF8300ax in gene expression or protein abundance of any virulence factor (<3-fold) we assessed. This lack of differential expression likely explains why we saw no significant difference in virulence between SF8300 and SF8300ax in either of the animal models. Our data are in agreement with those of Diep et al., who used microarray analysis to show similar expression in a wild-type parent strain and an isogenic ACME deletion mutant of nearly all USA300 S. aureus genes studied (8).

There are several limitations to our study. We studied experimental disease in rodents. Additional information will be necessary to explore the relevance of our observations to human patients. Also, the subcutaneous inoculation technique we used did not allow bacterial colonization of the skin prior to the onset of infection, and, therefore, may not have accurately mimicked the medically relevant pathogenesis of human skin and soft tissue infections. It should be emphasized that even the ACME-negative isolates contained a nonidentical arc operon, which could play a role similar to that of ACME-arcA.

In conclusion, although our studies do not discount the possibility that ACME could provide a selective advantage to USA300 by facilitating persistence within a host or transmission among hosts, we have demonstrated that its presence in USA300 is not associated with increased virulence in several experimental models of invasive CA-MRSA disease.

Acknowledgments

This work was supported by (i) an NICHD Research Training in Pediatrics grant (5K12HD043387-04) to C.P.M.; (ii) the Children's Research Foundation, University of Chicago (C.P.M.); (iii) the NIAID (R01AI40481 and 1R01AI067584 to R.S.D. and S.B.-V.); (iv) the Centers for Disease Control and Prevention (R01CCR523379 to R.S.D. and S.B.-V., R01CI000373 to R.S.D. and S.B.-V., and U01-CI000384 to R.S.D.); and (v) the Grant HealthCare Foundation (R.S.D. and S.B.-V.). R.S.D. and S.B.-V. received grant support from BD GeneOhm Sciences.

R.S.D. reports serving on paid advisory boards for Clorox, Sanofi Pasteur, GlaxoSmithKline, Pfizer, and the MRSA National Faculty Meeting (sponsored by Astellas and Theravance); the University of Chicago has received grant support from Clorox, Pfizer, Sage Products, and Sanofi Pasteur.

Editor: A. Camilli

Footnotes

▿

Published ahead of print on 20 April 2009.

REFERENCES

  • 1.Brown, E. L., O. Dumitrescu, D. Thomas, C. Badiou, E. M. Koers, P. Choudhury, V. Vazquez, J. Etienne, G. Lina, F. Vandenesch, and M. G. Bowden. 2009. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin. Microbiol. Infect. 15156-164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bubeck Wardenburg, J., T. Bae, M. Otto, F. R. Deleo, and O. Schneewind. 2007. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 131405-1406. [DOI] [PubMed] [Google Scholar]
  • 3.Bubeck Wardenburg, J., A. M. Palazzolo-Ballance, M. Otto, O. Schneewind, and F. R. DeLeo. 2008. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J. Infect. Dis. 1981166-1170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bubeck Wardenburg, J., R. J. Patel, and O. Schneewind. 2007. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 751040-1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.David, M. Z., D. Glikman, S. E. Crawford, J. Peng, K. J. King, M. A. Hostetler, S. Boyle-Vavra, and R. S. Daum. 2008. What is community-associated methicillin-resistant Staphylococcus aureus? J. Infect. Dis. 1971235-1243. [DOI] [PubMed] [Google Scholar]
  • 6.Degnan, B. A., M. C. Fontaine, A. H. Doebereiner, J. J. Lee, P. Mastroeni, G. Dougan, J. A. Goodacre, and M. A. Kehoe. 2000. Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein. Infect. Immun. 682441-2448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Diep, B. A., S. R. Gill, R. F. Chang, T. H. Phan, J. H. Chen, M. G. Davidson, F. Lin, J. Lin, H. A. Carleton, E. F. Mongodin, G. F. Sensabaugh, and F. Perdreau-Remington. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367731-739. [DOI] [PubMed] [Google Scholar]
  • 8.Diep, B. A., G. G. Stone, L. Basuino, C. J. Graber, A. Miller, S. A. des Etages, A. Jones, A. M. Palazzolo-Ballance, F. Perdreau-Remington, G. F. Sensabaugh, F. R. DeLeo, and H. F. Chambers. 2008. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 1971523-1530. [DOI] [PubMed] [Google Scholar]
  • 9.Furtado, N., P. D. Mangat, A. L. Frank, W. M. Janda, S. Boyle-Vavra, and R. S. Daum. 2006. Two clindamycin-susceptible (community-associated) MRSA (CA-MRSA) epidemics in Chicago, abstr. no. 378, p. P.117. Progr. Abstr. 44th Meet. Infect. Dis. Soc. Am. Toronto, Ontario, Canada.
  • 10.Goering, R. V., L. K. McDougal, G. E. Fosheim, K. K. Bonnstetter, D. J. Wolter, and F. C. Tenover. 2007. Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates. J. Clin. Microbiol. 451981-1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gómez, M. I., A. Lee, B. Reddy, A. Muir, G. Soong, A. Pitt, A. Cheung, and A. Prince. 2004. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat. Med. 10842-848. [DOI] [PubMed] [Google Scholar]
  • 12.Highlander, S. K., K. G. Hulten, X. Qin, H. Jiang, S. Yerrapragada, E. O. Mason, Jr., Y. Shang, T. M. Williams, R. M. Fortunov, Y. Liu, O. Igboeli, J. Petrosino, M. Tirumalai, A. Uzman, G. E. Fox, A. M. Cardenas, D. M. Muzny, L. Hemphill, Y. Ding, S. Dugan, P. R. Blyth, C. J. Buhay, H. H. Dinh, A. C. Hawes, M. Holder, C. L. Kovar, S. L. Lee, W. Liu, L. V. Nazareth, Q. Wang, J. Zhou, S. L. Kaplan, and G. M. Weinstock. 2007. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Klevens, R. M., M. A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, G. E. Fosheim, L. K. McDougal, R. B. Carey, and S. K. Fridkin. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2981763-1771. [DOI] [PubMed] [Google Scholar]
  • 14.Labandeira-Rey, M., F. Couzon, S. Boisset, E. L. Brown, M. Bes, Y. Benito, E. M. Barbu, V. Vazquez, M. Hook, J. Etienne, F. Vandenesch, and M. G. Bowden. 2007. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 3151130-1133. [DOI] [PubMed] [Google Scholar]
  • 15.McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 415113-5120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Montgomery, C. P., S. Boyle-Vavra, P. V. Adem, J. C. Lee, A. N. Husain, J. Clasen, and R. S. Daum. 2008. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J. Infect. Dis. 198561-570. [DOI] [PubMed] [Google Scholar]
  • 17.Montgomery, C. P., and R. S. Daum. 2009. Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for Panton-Valentine leukocidin? Infect. Immun. 772159-2167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tenover, F. C., L. K. McDougal, R. V. Goering, G. Killgore, S. J. Projan, J. B. Patel, and P. M. Dunman. 2006. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J. Clin. Microbiol. 44108-118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Voyich, J. M., M. Otto, B. Mathema, K. R. Braughton, A. R. Whitney, D. Welty, R. D. Long, D. W. Dorward, D. J. Gardner, G. Lina, B. N. Kreiswirth, and F. R. DeLeo. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis. 1941761-1770. [DOI] [PubMed] [Google Scholar]
  • 20.Wang, C.-H., C.-Y. Lin, Y.-H. Luo, P.-J. Tsai, Y.-S. Lin, M. T. Lin, W.-J. Chuang, C.-C. Liu, and J.-J. Wu. 2005. Effects of oligopeptide permease in group a streptococcal infection. Infect. Immun. 732881-2890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Xiong, Y. Q., J. Willard, M. R. Yeaman, A. L. Cheung, and A. S. Bayer. 2006. Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J. Infect. Dis. 1941267-1275. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES